Enzastik Capsule, Soft
Enzalutamide
40 mg
Eugia Pharma Specialties Limited
| Pack size | 112's Pack |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 80.17 AED |
Indications
Enzastik Capsule, Soft is used for:
Enzalutamide is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Enzalutamide :
Mechanism of Action
Enzalutamide is a competitive androgen receptor inhibitor that effects multiple stages of the signalling pathway. It is able to inhibit androgen binding to its receptor, androgen receptor nuclear translocation, and subsequent interaction with DNA. As a result, proliferation of prostate cancer cells decreases which ultimately leads to apoptosis and decreased tumour volume.
Note
Enzastik 40 mg Capsule, Soft manufactured by Eugia Pharma Specialties Limited. Its generic name is Enzalutamide. Enzastik is availble in Saudi Arabia.
Farmaco SA drug index information on Enzastik Capsule, Soft is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.